Crohn's disease of the mouth: Report of a case

European Journal of Paediatric Dentistry

Volumn 12, Issue 3, 2011, Pages 198-200

  Litsas, G ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^b Kozani ^*  (Greece)

Author keywords

Corticosteroids; Crohn's disease; Retromolar corrugated lesion

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; PREDNISONE;

BURNING MOUTH SYNDROME; CASE REPORT; CHILD; CROHN DISEASE; HUMAN; MALE; MOUTH DISEASE; ORAL BLEEDING; REVIEW;

ANTI-INFLAMMATORY AGENTS; BURNING MOUTH SYNDROME; CHILD; CROHN DISEASE; GLUCOCORTICOIDS; HUMANS; MALE; MOUTH DISEASES; ORAL HEMORRHAGE; PREDNISONE;

EID: 84855172390     PISSN: 1591996X     EISSN: 2035648X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bevenius J. Caries risk in patients with Crohn's disease: a pilot study. Oral Surg Oral Med Oral Pathol 1988; 65(3):304-07.
2. Bernstein M, McDonald J. Oral lesions in Crohn's disease: Report of two cases and update of the literature. Oral Surg 1978; 46(2): 234-45.
3. Crohn, B, Ginzburg L, Oppenheimer, GD. J Am Dent Assoc 1932; 99:1323.
4. Damen GM, Hol J, De Ruiter L, Bouquet J et al. Chemokine production by buccal epithelium as a distinctive feature of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2006; 42(2):142-9.
5. Gugler R, Jensen JC, Schulte H, Vogel R. The course of Crohn's disease and the side effect profile with long-term treatment using metronidazole. Z Gastroenterol 1989; 27(11):676-82.
6. Gupta N, Bostrom AG, Kirchner BS, Ferry GD et al. Gender differences in presentation and course of disease in pediatric patients with Crohn disease. Pediatrics 2007; 120(6): 1418-25.
7. Halme L, Meurman HJ, Laine P, Smitten K, Syrjanen S, Lindqvist C, Strand-Pettinen I. Oral findings in patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol 1993; 76(2):175-81.
8. Harty S, Fleming P, Rowland M Crushell E et al. A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol. 2005; 3(9): 886-91.
9. Hegarty A, Hodgson T, Porter S. Thalomide for the treatment of recalcitrant oral Crohn's and orofacial granulomatosis. Oral Surg Oral Med Oral Pathol 2003; 95(5):576-85.
10. Jarnerot G, Jarnmark I, Nilsson K. Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol 1983; 18(8): 999-1002.
11. Lebwohl M, Lebwohl O. Cutaneous manifestations of inflammatory bowel disease. Inflamm Bowel Dis 1998; 4(2):142-48.
12. McDonald TT, Monteleone G, Pender SLF. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 2000;51(1):2-9.
13. Mahadevan U, Sandborn WJ. Infliximab for the treatment of orofacial Crohn's disease. Inflamm Bowel Dis 2001 Feb; 7(1):38-2.
14. Malins TJ, Wilson A, Ward-Booth RP. Recurrent buccal space abscesses: a complication of Crohn's disease. Oral Surg Oral Med Oral Pathol 1991; 72(1):19-21.
15. Meurman JH, Halme L, Laine P, vonSmitten K, Lindqvist C. Gingival and dental status, salivary acidogenic bacteria and yeast counts of patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol 1994; 77(5):465-68.
16. Ottavianni F, Schindler A, Capaccio P, Petrone M, Porro GB. New therapy for orolaryngeal manifestations of Crohn's disease. Ann Otol Rhinol Laryngol 2003; 112(1):37-9.
17. Pittock S, Drumm B, Fleming P, McDermott M, Imrie C, Flint S, Bourke B. The oral cavity in Crohn's disease. J Pediatr 2001; 138(5):767-71.
18. Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn's disease: an analysis of 79 cases. J Clin Gastroenterol 1991; 13(1):29-37.
19. Ponsky T, Hindle A, Sandler A. Inflammatory bowel disease in the pediatric patient. 2007; 87(3):643-58.
20. Rampton DS. Management of Crohn's disease. Brit Med J 1999; 319(7273):1480-85.
21. Rees TD. Orofacial granulomatosis and related conditions. Periodontology 2000 1999; 21:145-57.
22. Rooney TP. Dental caries prevalence in patients with Crohn's disease. Oral Surg 1984; 57(6):623-24.
23. Sundh B, Emilson CG. Salivary and microbial conditions and dental health in patients with Crohn's disease; a 3-year study. Oral Surg Oral Med Oral Pathol 1989; 67:286-90.
24. Sundh B, Johansson I, Emilson CG, Nordgren S, Birkhed D. Salivary antimicrobial proteins in patients with Crohn's disease. Oral Surg Oral Med Oral Pathol 1993; 76(5):564-69.
25. Sandborn JW Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease. Inflamm Bowel Dis 1999; 5(2):119-33.
26. Soames JV, Southam JC. Oral pathology. Oxford: Oxford University Press.;1998.p.231-44.
27. Simpson HE, Howell RA, Summersgill GB. Oral manifestations of Crohn's disease. J Oral Med 1974; 29(2):49-52.
28. Stricker T, Braegger CP. Images in clinical medicine. Oral manifestations of Crohn's disease. N Engl J Med 2000; 342(22):1644.
29. Varley BWE. Crohn's disease of the mouth: report of three cases. Oral Surg Oral Med Oral Pathol. 1972; 33(4):570-78.
30. Winter HS. Treatment of pyoderma gangrenosum, erythema nodosum and apthous ulcerations. Inflamm Bowel Dis 1998; 4(2):71.